In particular, we found that the activation of ERβ with a specific agonist was capable of affecting HL tumor growth triggering a complex framework of events able to potently induce autophagy and impair cell cycle progression and cell proliferation. The gene discussed is ESR2; the disease is Hodgkins lymphoma.